Alternate TextTo enhance service speed and avoid tariff delays, we've opened a US warehouse. All US orders ship directly from our US facility.
Home > Products

Products

You can also try the following methods, and our professionals will serve you Customized Consultation
Cat. No. Product Name Field of Application Chemical Structure
DC65901 PSB-1901 Featured
PSB-1901 is a potent A2B adenosine receptor (A2BAR) antagonist with Kis of 0.0835 nM and 0.131 nM for human and mouse A2BARs respectively. PSB-1901 can be used for the research of cancer.
More description
DC65899 Des-iPr-TAS-116 Featured
DC11286 WJ460 Featured
WJ460 is one of the lead compounds exerting anti-metastatic activity in the nanomolar range in breast cancer cells.
More description
DC72750 GNE-9822 Featured
GNE-9822 is a potent, orally active and selective ITK inhibitor with a Ki value of 0.7 nM. GNE-9822 has good ADME properties. GNE-9822 can be used in research of asthma.
More description
DC65898 LMTK3 inibitor C28 Featured
LMTK3-IN-1 (compound C28) is an ATP-competitive inhibitor of lemur tyrosine kinase 3 (LMTK3) (Kd=2.5 μM),that acts by degrading LMTK3 via the ubiquitin-proteasome pathway. LMTK3-IN-1 shows anticancer activity in a variety of cancer cell lines and in vivo BC mouse models. LMTK3-IN-1 induces apoptosis in BC cell lines at 10-20 μM.
More description
DC65897 SLU-PP-1072 Featured
SLU-PP-1072 is a novel Selective ERRα/γ Inverse Agonist, Inhibiting the Warburg Effect and Inducing Apoptosis in Prostate Cancer Cells.
More description
DC70798 SRX3177 Featured
SRX3177 is a potent, triple BRD4/PI3K/CDK4/6 inhibitor with nanomolar potency against PI3Kα (IC50=79 nM), BRD4 bromodomains (BD1 and BD2) (IC50=33 nM and 89 nM, respectively), and CDK4/6 (IC50=2.5/3.3 nM).SRX3177 is capable of targeting BRD4, PI3K and CDK4/6 simultaneously, induces apoptosis and cell cycle arrest and has in vitro efficacy in mantle cell lymphoma, hepatocellular carcinoma and neuroblastoma models.SRX3177 has antitumor efficacy in in vivo xenograft models and is less toxic than the combination of agents that inhibit individual targets.
More description
DC65896 PSB-15160 Featured
DC65895 5-Acetyl-2-bromobenzaldehyde Featured
DC65894 3-bromo-2-(2-hydroxyethyl)thiophene Featured
DC65893 Pyrithione Featured
Pyrithione, a Transition metal complexe, is a zinc ionophore that causes increased zinc levels within mammalian cells. Pyrithione has potent bactericidal and anti-fungal activity.
More description
DC65892 Cyclopropyl-prop-2-ynyl-amine Featured
DC47388 PROTAC SHP2 degrader-1 Featured
PROTAC SHP2 degrader-1 is a potent and effective SHP2 degrader. PROTAC SHP2 degrader-1 induces SHP2 degradation requires binding to VHL-1 and SHP2 proteins and is also neddylation- and proteasome-dependent.
More description
DC71874 MIF098 Featured
MIF098 is a macrophage migration inhibitory factor (MIF) antagonist. MIF098 inhibits proliferation, migration and fibrosis of pulmonary smooth muscle cells. MIF098 can be used for immunoinflammation-related disease research.
More description
DC43804 VAS3947 Featured
Selective inhibitor of NADPH oxidase activity in low micromolar concentrations, interfering neither with ROS detection nor with XOD or eNOS activities
More description
DC65891 GI 181771 Featured
GI 181771 is a cholecystokinin 1 receptor agonist investigated for the treatment of obesity.
More description
DC44929 Cyclotriazadisulfonamide Featured
Cyclotriazadisulfonamide (CADA) is a specific CD4-targeted HIV entry inhibitors. Cyclotriazadisulfonamide (CADA) inhibits the co-translational translocation of human CD4 (huCD4) into the ER lumen in a signal peptide (SP)-dependent way.
More description
DC65889 3-Oxa-1-azaspiro[4.5]decane-2,4-dione Featured
DC65888 2,4,6-Triisopropyl-m-phenylene diisocyanate Featured
DC65886 MCU-i11 Featured
MCU-i11 is a novel negative modulator of the MCU, binding MICU1 and impairing muscle cell growth.
More description
DC21437 OAT-2068 Featured
OAT-2068 is a potent, selective, orally bioavailable inhibitor of mouse chitotriosidase (mCHIT1) with IC50 of 29 nM, 143-fold selectivity over mAMCase.
More description
DC34054 PHPS1 Featured
PHPS1 is an inhibitor of the protein tyrosine phosphatase Shp2. PHPS1 also efficiently inhibits activation of Erk1/2 by the leukemia-associated Shp2 mutant, Shp2-E76K, and blocks the anchorage-independent growth of a variety of human tumor cell lines.
More description
DC12414 ZLc002 Featured
ZLc002 (ZLc-002) is a putative small-molecule inhibitor of nNOS interaction with NOS1AP, disrupts neuronal nitric oxide synthase-NOS1AP interaction in intact cells.
More description
DC65885 Stilbamidine dihydrochloride Featured
Stilbamidine dihydrochloride is a blocker of neuromuscular transmission and axonal conduction. It is used to study the distribution of the drug in the organs and tissues of rats following intravenous injection.
More description
DC65884 CCR2-RA Featured
DC42752 HaloPROTAC3 Featured
HaloPROTAC3 is a degrader of HaloTag fusion proteins.
More description
DC65883 3,5-Dichloro-6-iodopyrazolo[1,5-a]pyrimidine Featured
DC65882 Methyl 2-Formyl-1H-Pyrrole-3-Carboxylate Featured
DC65881 Afabicin Featured
Afabicin (formerly Debio 1450, AFN-1720) is a prodrug of afabicin desphosphono, an enoyl-acyl carrier protein reductase (FabI) inhibitor, and is a first-in-class antibiotic with a novel mode of action to specifically target fatty acid synthesis in Staphylococcus spp.
More description
DC65880 HaloPROTAC-E Featured
HaloPROTAC-E is a novel HaloPROTAC potent degrader, inducing reversible degradation of two endosomally localized proteins, SGK3 and VPS34, with a DC50 of 3-10 nM, remarkably selective inducing only degradation of the Halo tagged endogenous VPS34 complex (VPS34, VPS15, Beclin1, and ATG14) and no other proteins were significantly degraded.
More description

Customized Consultation X

Your information is safe with us. * Required Fields.

Your name
Company
Email
Procuct Name
Cat. No.
Remark
Verification code
Please fill out the characters in the picture
X